ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,994, issued on April 14, was assigned to CORBION BIOTECH INC. (South San Francisco, Calif.).

"Beta-ketoacyl-ACP synthase IV variants" was invented by Joshua Ferreira (South San Francisco, Calif.), Janice Lau Wee (South San Francisco, Calif.) and Nien-Hsi Ko (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are non-natural or variant Beta-ketoacyl-acyl carrier protein (ACP) synthase (KAS) IVa enzymes (KASIVa), polynucleotides encoding such variant KASIVa, host cells expressing such variant KASIVa, oils and oil products produced by such cells, and methods of making and using such variant KASIVa."

The patent was fil...